Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
Conditions: Oligometastatic Disease; Oligoprogression; Toxicity Due to Radiotherapy; Quality of Life Interventions: Radiation: Single fraction SABR; Radiation: Multiple fraction SABR; Other: QoL reporting alone; Other: QoL reporting, symptom screen and healthcare provider intervention Sponsors: British Columbia Cancer Agency; London Regional Cancer Program, Canada; Tom Baker Cancer Centre; Princess Margaret Hospital, Canada Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials